SIILTIBCY (Serum Life Science Europe GmbH)

by Pelican Press
0 minutes read

SIILTIBCY (Serum Life Science Europe GmbH)

SIILTIBCY (Active substance: rdESAT-6 and rCFP-10) – Centralised – Authorisation – Commission Decision (2025)263 of Mon, 13 Jan 2025 – European Medicines Agency (EMA) procedure number: EMEA/H/C/006177/0000


Source link

#SIILTIBCY #Serum #Life #Science #Europe #GmbH

You may also like